CSI Compressco (CCLP) 10-Q 16 May 22 2022 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2022	May 13, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2022
Document Transition Report	false
Entity File Number	001-35195
Entity Registrant Name	CSI Compressco LP
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	94-3450907
Entity Address, Address Line One	1735 Hughes Landing Boulevard, Suite 200
Entity Address, City or Town	The Woodlands,
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	77380
City Area Code	832
Local Phone Number	365-2257
Title of 12(b) Security	COMMON UNITS REPRESENTING LIMITED PARTNERSHIP INTERESTS
Trading Symbol	CCLP
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Common Stock Shares Outstanding		141,213,944
Entity Central Index Key	0001449488
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Amendment Flag	false

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenues:
Total revenues	$ 80,012	$ 69,766
Cost of revenues (excluding depreciation and amortization expense):
Total cost of revenues	42,641	37,456
Depreciation and amortization	19,359	19,134
Selling, general, and administrative expense	10,841	10,301
Interest expense, net of capitalized interest of $78 in 2022 and $34 in 2021	12,381	13,708
Other expense, net	544	294
Loss before taxes and discontinued operations	(5,754)	(11,127)
Provision for income taxes	816	1,706
Loss from continuing operations	(6,570)	(12,833)
Loss from discontinued operations, net of taxes	0	(62)
Net loss	(6,570)	(12,895)
General partner interest in net loss	(31)	(179)
Common units interest in net loss	$ (6,539)	$ (12,716)
Basic and diluted net loss per common unit:
Loss from continuing operations per common unit, basic (in dollars per share)	$ (0.05)	$ (0.27)
Loss from continuing operations per common unit, diluted (in dollars per share)	(0.05)	(0.27)
Income (loss) from discontinued operations per common unit, basic (in dollars per share)	0	0
Income (loss) from discontinued operations per common unit, diluted (in dollars per share)	0	0
Net loss per common unit, basic (in dollars per share)	(0.05)	(0.27)
Net loss per common unit, diluted (in dollars per share)	$ (0.05)	$ (0.27)
Weighted average common units outstanding:
Basic (in shares)	140,770,406	47,723,874
Diluted (in shares)	140,770,406	47,723,874
Contract services
Revenues:
Total revenues	$ 62,807	$ 56,237
Cost of revenues (excluding depreciation and amortization expense):
Total cost of revenues	31,040	27,397
Aftermarket services
Revenues:
Total revenues	12,868	11,034
Cost of revenues (excluding depreciation and amortization expense):
Total cost of revenues	10,633	9,545
Equipment rentals
Revenues:
Total revenues	3,500	2,025
Cost of revenues (excluding depreciation and amortization expense):
Total cost of revenues	516	154
Equipment sales
Revenues:
Total revenues	837	470
Cost of revenues (excluding depreciation and amortization expense):
Total cost of revenues	$ 452	$ 360

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Statement of Comprehensive Income [Abstract]
Net loss	$ (6,570)	$ (12,895)
Foreign currency translation adjustment, net of tax of $0 in 2022 and 2021	12	57
Comprehensive loss	$ (6,558)	$ (12,838)

Consolidated Statements of Co_2

Consolidated Statements of Comprehensive Income (Loss) (Unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Statement of Comprehensive Income [Abstract]
Foreign currency translation adjustment, tax	$ 0	$ 0

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 17,294	$ 6,598
Trade accounts receivable, net of allowance for doubtful accounts of $1,231 as of March 31, 2022 and $1,223 as of December 31, 2021	65,256	53,520
Inventories	38,360	33,271
Prepaid expenses and other current assets	5,985	7,390
Total current assets	126,895	100,779
Property, plant, and equipment:
Land and building	9,087	13,409
Compressors and equipment	1,094,369	1,072,927
Vehicles	8,464	8,469
Construction in progress	14,925	31,968
Total property, plant, and equipment	1,126,845	1,126,773
Less accumulated depreciation	(568,593)	(556,311)
Net property, plant, and equipment	558,252	570,462
Other assets:
Intangible assets, net of accumulated amortization of $34,411 as of March 31, 2022 and $33,672 as of December 31, 2021	21,356	22,095
Operating lease right-of-use assets	29,755	25,898
Deferred tax asset	5	5
Other assets	3,400	3,122
Total other assets	54,516	51,120
Total assets	739,663	722,361
Current liabilities:
Accounts payable	33,945	28,958
Accrued liabilities and other	53,235	42,075
Amounts payable to affiliates	682	0
Current liabilities associated with discontinued operations	262	262
Total current liabilities	88,124	71,295
Other liabilities:
Long-term debt, net	630,182	631,141
Deferred tax liabilities	876	819
Operating lease liabilities	21,469	17,648
Other long-term liabilities	5,770	299
Total other liabilities	658,297	649,907
Commitments and contingencies
Partners’ capital:
General partner interest	(1,524)	(1,486)
Common units (141,213,944 units issued and outstanding at March 31, 2022 and 140,386,811 units issued and outstanding at December 31, 2021)	9,158	17,049
Accumulated other comprehensive loss	(14,392)	(14,404)
Total partners’ capital	(6,758)	1,159
Total liabilities and partners’ capital	$ 739,663	$ 722,361

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Current assets:
Trade accounts receivable, allowances for doubtful accounts	$ 1,231	$ 1,223
Intangible assets, accumulated amortization	$ 34,411	$ 33,672
Partners’ capital:
Common units issued (in shares)	141,213,944	140,386,811
Common units outstanding (in shares)	141,213,944	140,386,811

Consolidated Statements of Part

Consolidated Statements of Partners' Capital (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	General Partner	Common Unitholders	Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2020	$ (25,333)	$ (885)	$ (10,055)	$ (14,393)
Beginning balance (in shares) at Dec. 31, 2020			47,352
Partners' capital rollforward
Net loss	(12,895)	(179)	$ (12,716)
Distributions	(484)	(7)	(477)
Equity compensation, net	474		$ 474
Vesting of phantom units (in shares)			619
Translation adjustment, net of taxes	57	0	$ 0	57
Partners' capital account, acquisitions	26,444		26,444
Other	(141)		(141)	0
Ending balance at Mar. 31, 2021	(11,878)	(1,071)	$ 3,529	(14,336)
Ending balance (in shares) at Mar. 31, 2021			47,971
Beginning balance at Dec. 31, 2021	1,159	(1,486)	$ 17,049	(14,404)
Beginning balance (in shares) at Dec. 31, 2021			140,386
Partners' capital rollforward
Net loss	(6,570)	(31)	$ (6,539)	0
Distributions	(1,411)	(7)	(1,404)	0
Equity compensation, net	52	0	$ 52	0
Vesting of phantom units (in shares)			828
Translation adjustment, net of taxes	12	0	$ 0	12
Ending balance at Mar. 31, 2022	$ (6,758)	$ (1,524)	$ 9,158	$ (14,392)
Ending balance (in shares) at Mar. 31, 2022			141,214

Consolidated Statements of Pa_2

Consolidated Statements of Partners' Capital (Unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Statement of Partners' Capital [Abstract]
Distributions (in USD per units)	$ 0.01	$ 0.01
Foreign currency translation adjustment, tax	$ 0	$ 0

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating activities:
Net loss	$ (6,570)	$ (12,895)
Reconciliation of net loss to cash provided by operating activities:
Depreciation and amortization	19,359	19,134
Provision for deferred income taxes	39	392
Equity compensation expense	52	474
Provision for doubtful accounts	22	149
Amortization of deferred financing costs	125	191
Other non-cash charges and credits	953	42
Gain on sale of property, plant, and equipment	231	(53)
Changes in operating assets and liabilities:
Accounts receivable	(11,805)	(4,678)
Inventories	(7,720)	(3,455)
Prepaid expenses and other current assets	1,105	(3,336)
Accounts payable and accrued expenses	15,194	15,045
Other	785	534
Net cash provided by (used in) operating activities	11,770	11,544
Investing activities:
Purchases of property, plant, and equipment, net	(9,202)	(4,565)
Proceeds from sale of property, plant, and equipment	3,267	157
Net cash used in investing activities	(5,935)	(3,234)
Financing activities:
Proceeds from long-term debt	4,227	11
Payments of long-term debt	(5,568)	(2,521)
Distributions	(1,411)	(484)
Other financing activities	7,612	(156)
Net cash used in financing activities	4,860	(3,150)
Effect of exchange rate changes on cash	1	(12)
Increase (decrease) in cash and cash equivalents and restricted cash	10,696	5,148
Cash and cash equivalents at beginning of period	6,598	16,577
Cash and cash equivalents and restricted cash at end of period	17,294	21,725
Supplemental cash flow information:
Interest paid	6	2,926
Income taxes paid	2,151	327
Decrease (increase) in accrued capital expenditures	(756)	218
Affiliate From TETRA
Investing activities:
Acquisition of affiliate	0	5
Other Affiliate
Investing activities:
Acquisition of affiliate	$ 0	$ 1,169

Consolidated Statements of Op_2

Consolidated Statements of Operations (Unaudited) (Parentheticals) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Capitalized interest	$ 78	$ 34

Organization, Basis of Presenta

Organization, Basis of Presentation, and Significant Accounting Policies	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Organization, Basis of Presentation, and Significant Accounting Policies	ORGANIZATION, BASIS OF PRESENTATION, AND SIGNIFICANT ACCOUNTING POLICIES Organization CSI Compressco LP, a Delaware limited partnership, is a provider of compression and treating services. Natural gas compression is used for oil production, gathering, artificial lift, transmission, processing, and storage. Treating services include the removal of contaminants from a natural gas stream and cooling to reduce the temperature of produced gas and liquids. We also sell used standard compressor packages and provide aftermarket services and compressor package parts and components manufactured by third-party suppliers. We provide contract and treating services and compressor parts and component sales to a broad base of natural gas and oil exploration and production, midstream, and transmission companies operating throughout many of the onshore producing regions of the United States as well as in a number of international locations, including the countries of Mexico, Canada, Argentina, Egypt and Chile. Previously, our equipment sales (new unit sales) business included the fabrication and sale of new standard and custom-designed, engineered compressor packages fabricated primarily at our facility in Midland, Texas. In the fourth quarter of 2020, we fully exited the new unit sales business and we have reflected these operations as discontinued operations for all periods presented. See Note 2 - “Discontinued Operations.” Used equipment sales revenue continues to be included in equipment sales revenue. Unless the context requires otherwise, when we refer to “the Partnership,” “we,” “us,” and “our,” we are describing CSI Compressco LP and its wholly owned subsidiaries. Presentation Our unaudited consolidated financial statements include the accounts of our wholly owned subsidiaries. All intercompany balances and transactions have been eliminated. In the opinion of our management, our unaudited consolidated financial statements as of March 31, 2022, and for the three-month periods ended March 31, 2022 and March 31, 2021 include all normal recurring adjustments that are necessary to provide a fair statement of our results for these interim periods. Operating results for the three-month period ended March 31, 2022 are not necessarily indicative of results that may be expected for the twelve months ended December 31, 2022. The accompanying unaudited consolidated financial statements have been prepared in accordance with Rule 10-01 of Regulation S-X for interim financial statements required to be filed with the U.S. Securities and Exchange Commission (“SEC”) and do not include all information and footnotes required by U.S. generally accepted accounting principles (“U.S. GAAP”) for complete financial statements. These financial statements should be read in conjunction with the financial statements for the year ended December 31, 2021 and notes thereto included in our Annual Report on Form 10-K , which we filed with the SEC on March 14, 2022. On November 10, 2021, the Partnership entered into a Contribution Agreement (the “Contribution Agreement”) by and among the Partnership, CSI Compressco GP LLC, a Delaware limited liability company (our “general partner”), Spartan Energy Partners, LP, a Delaware limited partnership (“Spartan”) and CSI Compressco Sub Inc., a Delaware corporation (“Compressco Sub”). Pursuant to the terms of the Contribution Agreement, Spartan contributed to the Partnership 100% of the limited liability company interest in Treating Holdco, LLC, a Delaware limited liability company (“Treating Holdco”), 100% of the common stock in Spartan Terminals Operating, Inc., a Delaware corporation (“Spartan Terminals”), and 99% of the limited liability company interests in Spartan Operating Company LLC, a Delaware limited liability company (“Spartan Operating” and together with Treating Holdco and Spartan Terminals, “Spartan Treating”) (such interests in Spartan Treating, the “Contributed Interests”) in exchange for 48.4 million common units in the partnership. We refer to the acquisition of the contributed interests as the “Spartan Acquisition.” The Spartan Acquisition was accounted for as a change in reporting entity between entities under common control in accordance with ASC 250-10-45-21. A change in reporting entity requires retrospective application for all periods as if the Spartan Acquisition had been in effect since inception of common control. As a result, the consolidated financial statements and notes thereto for the Partnership reflected in this report have been prepared as if the change in reporting entity occurred on January 29, 2021. See Note 4 - “Common Control Acquisition,” for a description of the transaction. Segments Our general partner has concluded that we operate in one reportable segment. Business Combinations When we acquire a business from an entity under common control, whereby the companies are ultimately controlled by the same party or parties both before and after the transaction, it is treated similar to the pooling of interests method of accounting. The assets and liabilities are recorded at the transferring entity’s historical cost instead of reflecting the fair value of assets and liabilities. Accordingly, the financial statements reflect the combined entities at historical carrying values from the date of common control for the three months ended March 31, 2022 and March 31,2021. Significant Accounting Policies Our significant accounting policies are described in the notes to our consolidated financial statements for the year ended December 31, 2021 included in our Annual Report on Form 10-K . There have been no significant changes in our accounting policies or the application thereof during the three months ended March 31, 2022. Use of Estimates The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclose contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues, expenses, and impairments during the reporting period. Actual results could differ from those estimates, and such differences could be material. Reclassifications C ertain previously reported financial information has been reclassified to conform to the current year’s presentation. Unless otherwise noted, amounts and disclosures throughout these Notes to Consolidated Financial Statements relate solely to continuing operations and exclude all discontinued operations. Cash Equivalents We consider all highly liquid cash investments with maturities of three months or less when purchased to be cash equivalents. We have concentrated credit risk for cash by maintaining deposits in a major bank, which may at times exceed amounts covered by insurance provided by the United States Federal Deposit Insurance Corporation (“FDIC”). We monitor the financial health of the bank and have not experienced any losses in such accounts and believe we are not exposed to any significant credit risk. Management believes the financial institutions are financially sound and risk of loss is minimal. Financial Instruments Financial instruments that subject us to concentrations of credit risk consist principally of trade accounts receivable, which are primarily due from companies of varying size engaged in oil and gas activities in the United States, Canada, Mexico, Argentina, Chile and Egypt. Our policy is to review the financial condition of customers before extending credit and periodically updating customer credit information. Payment terms are on a short-term basis. The risk of loss from the inability to collect trade receivables is heightened during prolonged periods of low oil and natural gas commodity prices. We have currency exchange rate risk exposure related to transactions denominated in a foreign currency as well as to investments in certain of our international operations. Our risk management activities include the use of foreign currency forward purchase and sale derivative contracts as part of a program designed to mitigate the currency exchange rate risk exposure on selected international operations. We have $58.5 million outstanding under our variable rate revolving credit facilities as of March 31, 2022 and face market risk exposure related to changes in applicable interest rates. Foreign Currencies We have designated the Canadian dollar as the functional currency for our operations in Canada. We are exposed to fluctuations between the U.S. dollar and certain foreign currencies, including the Canadian dollar, the Mexican peso, the Argentine peso, the Egyptian pound, and the Chilean peso as a result of our international operations. Foreign currency exchange (gains) losses are included in other (income) expense, net and totaled $0.4 million and $0.4 million during the three-month periods ended March 31, 2022 and 2021 , respectively. Leases Lessee As a lessee, unless the lease meets the criteria of short-term and is excluded per our policy election described below, we initially recognize a lease liability and related right-of-use asset on the commencement date. The right-of-use asset represents our right to use an underlying asset and the lease liability represents our obligation to make lease payments to the lessor over the lease term. All of our long-term leases are operating leases and are included in operating lease right-of-use assets, accrued liabilities and other, and operating lease liabilities in our consolidated balance sheet as of March 31, 2022 and December 31, 2021. We determine whether a contract is or contains a lease at inception of the contract. Where we are a lessee in a contract that includes an option to extend or terminate the lease, we include the extension period or exclude the period covered by the termination option in our lease term in determining the right-of-use asset and lease liability, if it is reasonably certain that we would exercise the option. As an accounting policy election, we do not include short-term leases on our balance sheet. Short-term leases include leases with a term of 12 months or less, inclusive of renewal options we are reasonably certain to exercise. The lease payments for short-term leases are included as operating lease costs on a straight-line basis over the lease term in cost of revenues or selling, general, and administrative expense based on the use of the underlying asset. We recognize lease costs for variable lease payments not included in the determination of a lease liability in the period in which an obligation is incurred. As allowed by U.S. GAAP, we do not separate nonlease components from the associated lease component for our contract services contracts and instead account for those components as a single component based on the accounting treatment of the predominant component. In our evaluation of whether Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 842 “Leases” or ASC 606 “Revenue from Contracts with Customers” is applicable to the combined component based on the predominant component, we determined the services nonlease component is predominant, resulting in the ongoing recognition of our compression services contracts following ASC 606. Our operating leases are recognized at the present value of lease payments over the lease term. When the implicit discount rate is not readily determinable, we use our incremental borrowing rate to calculate the discount rate used to determine the present value of lease payments. Consistent with other long-lived assets or asset groups that are held and used, we test for impairment of our right-of-use assets when impairment indicators are present. Lessor Our agreements for rental equipment contain an operating lease component under ASC 842 because we, as the lessor, retain substantial exposure to changes in the underlying asset’s value, unlike a sale or secured lending arrangement. Therefore, we do not unrecognize the underlying asset, and recognize income associated with providing the lessee the right to control the use of the asset ratably over the lease term. As a lessor, we recognize operating lease revenue on our statements of operations as equipment rentals. This revenue is recognized on a straight-line basis over the term of the lease based on the monthly rate in the agreement. The leased asset remains on the balance sheets consistent with other property, plant and equipment. Cash receipts associated with all leases are classified as cash flows from operating activities in the statements of cash flows. The leased equipment primarily consists of the Spartan Treating amine plants, cooling units and production equipment. All of this equipment is modular and skid mounted. It can be moved between locations. Lease terms for this equipment vary in length. Amine plants range from one to five years while the cooling units range from six months to two years. Inventories Inventories consist primarily of compressor package parts and supplies and work in process and are stated at the lower of cost or net realizable value. For parts and supplies, cost is determined using the weighted average cost method. The cost of work in progress is determined using the specific identification method. Impairments and Other Charges Impairments of long-lived assets, including identified intangible assets, are determined periodically, when indicators of impairment are present. If such indicators are present, the determination of the amount of impairment is based on our judgments as to the future undiscounted operating cash flows to be generated from the relevant assets throughout their remaining estimated useful lives. If these undiscounted cash flows are less than the carrying amount of the related asset, an impairment is recognized for the excess of the carrying value over its fair value. Fair value of intangible assets is generally determined using the discounted present value of future cash flows using discount rates commensurate with the risks inherent with the specific assets. Assets held for disposal are recorded at the lower of carrying value or estimated fair value less estimated selling costs. We did not record any impairments of long-lived assets during the three-month periods ended March 31, 2022 and March 31, 2021. Income Taxes Our operations are not subject to U.S. federal income tax other than the operations that are conducted through taxable subsidiaries. We incur state and local income taxes in certain areas of the U.S. in which we conduct business. We incur income taxes and are subject to withholding requirements related to certain of our operations in Latin America, Canada, and other foreign countries in which we operate. Furthermore, we also incur Texas Margin Tax, which, in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 740, is classified as an income tax for reporting purposes. A portion of the carrying value of certain deferred tax assets is subject to a valuation allowance. Earnings Per Common Unit Our computations of earnings per common unit are based on the weighted average number of common units outstanding during the applicable period. Basic earnings per common unit are determined by dividing net income (loss) allocated to the common units after deducting the amount allocated to our g eneral partner (including any distributions to our g eneral partner on its incentive distribution rights) by the weighted average number of outstanding common units during the period. When computing earnings per common unit under the two class method in periods when distributions are greater than earnings, the amount of the distribution is deducted from net income (loss) and the excess of distributions over earnings is allocated between the general partner and common units based on how our Partnership Agreement allocates net losses. Diluted earnings per common unit are computed using the treasury stock method, which considers the potential future issuance of limited partner common units. Unvested phantom units are not included in basic earnings per common unit, as they are not considered to be participating securities, but are included in the calculation of diluted earnings per common unit. For the three-month periods ended March 31, 2022 and March 31, 2021, all unvested phantom units were excluded from the calculation of diluted common units because the impact was anti-dilutive. Fair Value Measurements We utilize fair value measurements to account for certain items and account balances within our consolidated financial statements. We utilize fair value measurements on a recurring basis in the accounting for our foreign currency forward purchase and sale derivative contracts. For these fair value measurements, we utilize the quoted value (a Level 2 fair value measurement). Refer to Note 9 – “Fair Value Measurements” for further discussion. Fair value measurements are also utilized on a nonrecurring basis, such as in the allocation of purchase consideration for acquisition transactions to the assets and liabilities acquired, including intangible assets (a Level 3 fair value measurement) and for the impairment of long-lived assets (a Level 3 fair value measurement). Distributions On April 19, 2022, the board of directors of our general partner declared a cash distribution attributable to the quarter ended March 31, 2022 of $0.01 per outstanding common unit. This distribution equates to a distribution of $0.04 per outstanding common unit on an annualized basis. This quarterly distribution was paid on May 13, 2022 to each of the holders of common units of record as of the close of business on April 30, 2022. New Accounting Pronouncements Standards adopted in 2022 We did not adopt any new standards in 2022. Standards not yet adopted In June 2016, the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” ASU 2016-13 amends the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which will result in the more timely recognition of losses on financial instruments not accounted for at fair value through net income. The provisions require credit impairments to be measured over the contractual life of an asset and developed with consideration for past events, current conditions, and forecasts of future economic information. Credit impairments will be accounted for as an allowance for credit losses deducted from the amortized cost basis at each reporting date. Updates at each reporting date after initial adoption will be recorded through selling, general, and administrative expense. ASU 2016-13 is effective for us the first quarter of the 2023 fiscal year. We continue to assess the potential effects of these changes to our consolidated financial statements.

Discontinued Operations

Discontinued Operations	3 Months Ended
	Mar. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	DISCONTINUED OPERATIONSOn July 2, 2020, we completed the sale of our Midland manufacturing facility. The Midland facility was used to design, fabricate and assemble new standard and customized compressor packages for our new unit sales business. In connection with the Midland manufacturing facility sale, we entered into an agreement with the buyer to continue to operate a portion of the facility, which allowed us to close out the remaining backlog for the new unit sales business and to continue to operate our aftermarket services business at that location for an interim period. Following completion of the last unit in October 2020, we ceased fabricating new compressor packages for sales to third parties or for our own service fleet. The operations associated with the new unit sales business were previously reported in equipment sales revenues and are now reflected as discontinued operations in our financial statements for all periods presented. Used equipment sales revenue continues to be included in equipment sales revenue. A summary of financial information related to our discontinued operations for the new unit sales business is as follows: Reconciliation of the Line Items Constituting Pretax Loss from Discontinued Operations to the After-Tax Income (Loss) from Discontinued Operations (in thousands) Three Months Ended 2022 2021 Revenue $ — $ — Cost of revenues — 22 Depreciation and amortization — — Impairments of long-lived assets — — General and administrative expense — 40 Total pretax loss from discontinued operations — (62) Income tax provision — — Total loss from discontinued operations $ — $ (62) Reconciliation of Major Classes of Assets and Liabilities of the Discontinued Operations to Amounts Presented Separately in the Statement of Financial Position (in thousands) March 31, 2022 December 31, 2021 Carrying amounts of major classes of assets included as part of discontinued operations Inventories $ — $ — Other Current Assets — — Current assets of discontinued operations $ — $ — Carrying amounts of major classes of liabilities included as part of discontinued operations Accrued liabilities $ 262 $ 262 Current liabilities of discontinued operations $ 262 $ 262

Revenue from Contracts with Cus

Revenue from Contracts with Customers	3 Months Ended
	Mar. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenue from Contracts with Customers	REVENUE FROM CONTRACTS WITH CUSTOMERS As of March 31, 2022 , we had $63.3 million of remaining contractual performance obligations for compression services. As a practical expedient, thi s amount does not include revenue for compression service contracts whose original expected duration is less than twelve months an d does not consider the effects of the time value of money . Expected revenue to be recognized in the future as of March 31, 2022 for completion of performance obligations of compression service contracts are as follows: 2022 2023 2024 2025 Thereafter Total (In Thousands) Compression service contracts remaining performance obligations $ 42,970 $ 16,623 $ 3,343 $ 216 $ 120 $ 63,272 Our contract asset balances included in trade accounts receivable in our consolidated balance sheets, primarily associated with revenue accruals prior to invoicing, were $5.6 million and $4.1 million as of March 31, 2022 and December 31, 2021, respectively. The following table reflects the changes in unearned income in our consolidated balance sheets for the periods indicated: Three Months Ended 2022 2021 (In Thousands) Unearned income, beginning of period $ 2,187 $ 670 Additional unearned income 2,339 314 Revenue recognized (1,773) (320) Unearned income, end of period $ 2,753 $ 664 Unearned income is included in accrued liabilities and other on the consolidated balance sheets. As of March 31, 2022 and December 31, 2021, contract costs were immaterial. Disaggregated revenue from contracts with customers by geography is as follows: Three Months Ended 2022 2021 (In Thousands) Contract services United States $ 52,926 $ 47,878 International 9,881 8,359 62,807 56,237 Aftermarket services United States 12,689 10,843 International 179 191 12,868 11,034 Equipment rentals United States 1,966 1,140 International 1,534 885 3,500 2,025 Equipment sales United States 715 470 International 122 — 837 470 Total Revenue United States 68,296 60,331 International 11,716 9,435 $ 80,012 $ 69,766

Common Control Acquisition

Common Control Acquisition	3 Months Ended
	Mar. 31, 2022
Business Combinations [Abstract]
Common Control Acquisition	COMMON CONTROL ACQUISITION On November 10, 2021, the Partnership entered into the Contribution Agreement with the general partner, Spartan, and Compressco Sub. Pursuant to the terms of the Contribution Agreement, Spartan contributed Spartan Treating to the Partnership in exchange for the issuance of 48.4 million common units in the Partnership to Spartan. As the Partnership and Spartan Treating were under common control at the time of the Spartan Acquisition, the acquisition was deemed to be a transaction under common control under ASC 805, “Business Combinations.” Therefore, we accounted for this transaction at the carrying amount of the net assets acquired and the results of operations have been combined for the Partnership and Spartan Treating from the date of common control, which was January 29, 2021. Assets acquired and liabilities assumed are reported at their historical carrying amounts. The balance sheet of Spartan Treating on November 10, 2021, the date of acquisition, consisted of (in thousands): Current assets $ 6,616 Property, plant, and equipment 112,972 Less accumulated depreciation (53,039) Net property, plant, and equipment 59,933 Other assets 1,245 Total assets 67,794 Current liabilities 7,597 Long-term debt, net 32,590 Other liabilities 239 Total liabilities 40,426 Net assets $ 27,368 The Partnership’s consolidated financial statements as of March 31, 2022 and December 31, 2021 include the assets and liabilities of Spartan Treating, including intercompany eliminations. As the results of operations for Spartan Treating were consolidated as of January 29, 2021, the date common control began, the Partnership’s balances for Partners’ capital as of January 29, 2021 were adjusted to include Spartan Treating’s equity balances as of that date. On November 10, 2021, Partners capital associated with Spartan Treating was $27.4 million. In consolidation, Partners capital associated with Spartan Treating is eliminated. The consideration for the Spartan Treating acquisition was the issuance to Spartan of 48.4 million common units. The value of the common units was approximately $65.3 million. As the acquisition is accounted for as a transaction under common control and the transfer of assets and liabilities occurs at historical cost, the value of the common units has no impact on Partners’ capital. The difference between the consideration and the net assets acquired of $37.9 million is recognized as a deemed distribution as the book value of net assets as of November 10, 2021 was less than the consideration. As the Spartan Treating acquisition was accounted for retrospectively to the date of common control, the Partnership’s Consolidated Statement of Operations includes Spartan Treating’s net income of $1.6 million corresponding to the period from January 29, 2021 to March 31, 2021. The following tables include unaudited pro-forma financial information and the effect of the Spartan Acquisition after elimination of intercompany transactions. Three Months Ended March 31, 2021 CSI Spartan Treating Total (In Thousands, Unaudited) Revenue $ 65,710 $ 4,056 $ 69,766 Income (loss) from continuing operations $ (12,896) $ 1,769 $ (11,127) Net income (loss) $ (14,464) $ 1,569 $ (12,895)

Inventories

Inventories	3 Months Ended
	Mar. 31, 2022
Inventory Disclosure [Abstract]
Inventories	INVENTORIES Components of inventories as of March 31, 2022 and December 31, 2021, are as follows: March 31, 2022 December 31, 2021 (In Thousands) Parts and supplies $ 35,494 $ 31,441 Work in progress 2,866 1,830 Total inventories $ 38,360 $ 33,271 Inventories consist primarily of compressor package parts and supplies. Work in progress inventories consist of work in progress for our aftermarket business that has not been invoiced.

Leases

Leases	3 Months Ended
	Mar. 31, 2022
Leases [Abstract]
Leases	LEASES Lessor Accounting Our leased equipment primarily consists of amine plants, cooling units and other production equipment. Certain of our agreements with our customers for rental equipment contain an operating lease component under ASC 842 because (i) there are identified assets, (ii) the customer has the right to obtain substantially all of the economic benefits from the use of the identified asset throughout the period of use and (iii) the customer directs the use of the identified assets throughout the period of use. We have elected to apply the practical expedient provided to lessors to combine the lease and non-lease component of a contract where the revenue recognition pattern is the same and where the lease component, when accounted for separately, would be considered an operating lease. The practical expedient also allows a lessor to account for the combined lease and non-lease components under ASC 606, Revenue from Contracts with Customers, when the non-lease component is the predominant element of the combined component. Our lease agreements generally have contract terms based on monthly rates. Lease revenue is recognized straight-line based on these monthly rates. We do not provide an option for the lessee to purchase the rented assets at the end of the lease and the lessees do not provide residual value guarantees on the rented assets. We recognized operating lease revenue, which is included in “Equipment rentals” on the consolidated statements of operations as follows: March 31, 2022 March 31, 2021 (In Thousands) Equipment rentals 3,500 $ 2,025 The following table presents the maturity of lease payments for operating lease agreements in effect as of March 31, 2022. This presentation includes minimum fixed lease payments and does not include an estimate of variable lease consideration. These agreements have remaining lease terms ranging from 1 month to 7 years. The following table presents the undiscounted cash flows expected to be received related to these agreements: 2022 2023 2024 2025 2026 Thereafter (In Thousands) Future minimum lease revenue $ 8,807 5,518 1,744 1,599 1,576 3,421

Long-Term Debt and Other Borrow

Long-Term Debt and Other Borrowings	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Long-Term Debt and Other Borrowings	LONG-TERM DEBT AND OTHER BORROWINGS Long-term debt consists of the following: Scheduled Maturity March 31, 2022 December 31, 2021 (In Thousands) Credit Agreement (1) June 29, 2023 $ — $ 330 Spartan Credit Agreement (2) January 29, 2024 57,621 58,045 7.50% First Lien Notes due 2025 (3) April 1, 2025 398,964 399,767 10.00%/10.75% Second Lien Notes due 2026 (4) April 1, 2026 173,597 172,999 Total long-term debt $ 630,182 $ 631,141 (1) Net of unamortized deferred financing costs of $0.5 million as of December 31, 2021. Because there was no outstanding balance on the Credit Agreement, associated deferred financing costs of $0.1 million as of March 31, 2022 were classified as other long-term assets on the accompanying consolidated balance sheet. (2) Net of unamortized deferred financing costs of $0.9 million and $1.0 million as of March 31, 2022 and December 31, 2021, respectively. (3) Net of unamortized deferred financing costs of $4.2 million and $3.9 million as of March 31, 2022 and December 31, 2021, respectively, unamortized discount of $0.5 million and $0.2 million as of March 31, 2022 and December 31, 2021, respectively, and deferred restructuring gain of $3.6 million and $3.9 million as of March 31, 2022 and December 31, 2021, respectively. (4) Net of unamortized deferred financing costs of $1.2 million and $2.0 million as of March 31, 2022 and December 31, 2021, respectively, unamortized discount of $0.8 million and $0.9 million as of March 31, 2022 and December 31, 2021, respectively, and deferred restructuring gain of $2.9 million and $3.1 million as of March 31, 2022 and December 31, 2021, respectively. Our Credit Agreement and Senior Note agreements contain certain affirmative and negative covenants, including covenants that restrict the ability to pay dividends or other restricted payments. We are in compliance with all covenants of our credit and senior note agreements as of March 31, 2022. See Note 8 – “Related Party Transactions,” for a discussion of our amounts payable to affiliates and long-term affiliate payable to Spartan Energy Partners LP (“Spartan”). Credit Agreement On June 11, 2020, the Partnership amended the Loan and Security Agreement dated June 29, 2018 (as amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”). The Credit Agreement provides for maximum revolving credit commitments of $35.0 million and includes a $5.0 million reserve, which results in reduced borrowing availability. The Credit Agreement includes a $25.0 million sublimit for letters of credit. On January 29, 2021, the Partnership further amended the Credit Agreement to temporarily increase the size of the reserve to $10.0 million and also required that Spartan backstop all of the Partnership’s outstanding letters of credit. These temporary restrictions expired on April 30, 2021. On April 30, 2021, the required reserve on our Credit Agreement was reduced to $5.0 million and Spartan’s backstop for the Partnership’s outstanding letters of credits was released. On November 10, 2021, the Partnership and CSI Compressco Sub Inc., as borrowers, entered into the Fourth Amendment to Loan and Security Agreement (the “Amendment”) amending the Loan and Security Agreement dated June 29, 2018 (as amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”) with Bank of America, N.A., in its capacity as administrative agent, issuing bank and swing line issuer (“Administrative Agent”), and the other lenders and loan parties party thereto. The Amendment provided for changes and modifications to the Credit Agreement as set forth therein, which include, among other things, changes to certain terms of the Credit Agreement to permit: (i) the consummation of the Spartan Acquisition pursuant to the Contribution Agreement, and after giving effect to such Spartan Acquisition, for Spartan Terminals and Spartan Operating to become Immaterial Subsidiaries (as defined in the Credit Agreement) and Treating Holdco and its subsidiaries to become Unrestricted Subsidiaries (as defined in the Credit Agreement), in each case under the Credit Agreement and related loan documents; (ii) the sale by CSI Compressco Leasing LLC, a Delaware limited liability company and a subsidiary of the Partnership, and subsequent leaseback by CSI Compressco Operating LLC, a Delaware limited liability company and subsidiary of the Partnership, of certain compressor units with Treating Holdco and/or its subsidiaries occurring on or about the date of the Amendment (the “Spartan Sale/Leaseback”); and (iii) the consummation of the Redemption (as defined below) within 45 days following the date of the Amendment utilizing proceeds from the Spartan Sale/Leaseback, the Private Placement (as defined in our Annual Report on Form 10-K ) and the issuance of $10 million in aggregate principal amount of our 10.000%/10.750% Senior Secured Second Lien Notes due 2026 (the “New Second Lien Notes”. Refer to Note 8 - “Related Party Transactions,” for a discussion of the Spartan Acquisition and the Spartan Sale/Leaseback. As of March 31, 2022, and subject to compliance with the covenants, borrowing base, and other provisions of the agreements that may limit borrowings under the Credit Agreement, we had availability of $21.1 million. The maturity date of the Credit Agreement is June 29, 2023. As of March 31, 2022 we had no outstanding balance and had $2.1 million in letters of credit against our Credit Agreement. Spartan Credit Agreement On November 10, 2021, certain unrestricted subsidiaries of the Partnership, Spartan Energy Services LLC, as borrower, and Treating Holdco, as new guarantor, entered into the First Amendment to Loan, Security and Guaranty Agreement (the “Spartan Amendment”) amending the Loan, Security and Guaranty Agreement dated January 29, 2021 (as amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Spartan Credit Agreement”) with Bank of America, N.A., in its capacity as agent, and the other lenders and loan parties party thereto. The Spartan Amendment provided for changes and modifications to the Spartan Credit Agreement as set forth therein, which include, among other things, changes to certain terms of the Spartan Credit Agreement as follows: (i) increase in Commitments (as defined in the Spartan Credit Agreement) from $55,000,000 to $70,000,000; (ii) permit the consummation of the Spartan Acquisition pursuant to the Contribution Agreement, and after giving effect to such Spartan Acquisition, the release of each of Spartan, Spartan Terminals and Spartan Operating as Obligors (as defined in the Spartan Credit Agreement) and the joinder of Spartan Treating as a Guarantor (as defined in the Spartan Credit Agreement), in each case under the Spartan Credit Agreement and related loan documents; (iii) revise Change of Control (as defined in the Spartan Credit Agreement) to allow for Control (as defined in the Spartan Credit Agreement) by the Partnership and the general partner; and (iv) permit the Spartan Sale/Leaseback. Refer to Note 8 - “Related Party Transactions,” for a discussion of the Spartan Acquisition and the Spartan Sale/Leaseback. As of March 31, 2022, and subject to compliance with the covenants, borrowing base, and other provisions of the agreements that may limit borrowings under the Spartan Credit Agreement, we had availability of $5.1 million. The maturity date of the Spartan Credit Agreement is January 29, 2024. As of March 31, 2022, we had $58.5 million outstanding and no letters of credit against the Spartan Credit Agreement. 7.50% First Lien Notes due 2025 As of March 31, 2022, our 7.50% First Lien Notes due 2025 (the “First Lien Notes”) had $399.0 million outstanding net of unamortized discounts, unamortized deferred financing costs and deferred restructuring gains. Interest on these notes is payable on April 1 and October 1 of each year. The First Lien Notes are secured by a first-priority security interest in substantially all of the Partnership’s and its subsidiaries assets, subject to certain permitted encumbrances and exceptions, and are guaranteed on a senior secured basis by each of the Partnership’s U.S. restricted subsidiaries (other than Finance Corp, certain immaterial subsidiaries and certain other excluded U.S. subsidiaries). 10.000%/10.750% Second Lien Notes due 2026 As of March 31, 2022, our 10.000%/10.750% Second Lien Notes due 2026 (the “Second Lien Notes”) had $173.6 million outstanding, net of unamortized discounts, unamortized deferred financing costs and deferred restructuring gains. Interest on the Second Lien Notes is payable on April 1 and October 1 of each year. The Second Lien Notes are secured by a second-priority security interest in substantially all of the Partnership’s and its subsidiaries assets, subject to certain permitted encumbrances and exceptions, and are guaranteed on a senior secured basis by each of the Partnership’s U.S. restricted subsidiaries (other than Finance Corp and certain other excluded U.S. subsidiaries). In connection with the payment of PIK Interest (as defined below), if any, in respect of the Second Lien Notes, the issuers will be entitled, to increase the outstanding aggregate principal amount of the Second Lien Notes or issue additional notes (“PIK notes”) under the Second Lien Notes indenture on the same terms and conditions as the already outstanding Second Lien Notes. Interest will accrue at (1) the annual rate of 7.250% payable in cash, plus (2) at the election of the Issuers (made by delivering a notice to the Second Lien Trustee not less than five business days prior to the record date), the annual rate of (i) 2.750% payable in cash (together with the annual rate set forth in clause (1), the “Cash Interest Rate”) or (ii) 3.500% payable by increasing the principal amount of the outstanding Second Lien Notes or by issuing additional PIK notes, in each case rounding up to the nearest $1.00 (such increased principal amount or additional PIK notes, the “PIK Interest”). During the fourth quarter of 2021, the second quarter of 2021 and the second quarter of 2020, the Partnership elected to increase the principal amount outstanding through the issuance of PIK notes. As of March 31, 2022, our principal amount outstanding included $7.2 million of PIK notes. Finance Agreement During the first quarter of March 31, 2022, CSI Compressco Leasing LLC and CSI Compressco Operating LLC (individually and collectively as Debtor), with CSI Compressco LP (as Guarantor), entered into a Master Equipment Finance Agreement (the “Finance Agreement”) with a third party in the amount of $7.8 million to finance certain compression equipment. The note is payable in monthly installments of $0.2 million for 36 months. The current portion of this amount is classified in accrued liabilities and other and the long-term portion is classified in other long-term liabilities on the accompanying consolidated balance sheet.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions	RELATED PARTY TRANSACTIONS GP Sale On January 29, 2021, Spartan acquired from TETRA Technologies, Inc. (“TETRA”) the Partnership’s general partner, its incentive distribution rights (the “IDRs”) and 10.95 million common units in the Partnership (the “GP Sale”). The Partnership did not issue any common units or incur any debt as a result of the transaction. TETRA retained 5.2 million common units of the Partnership. Acquisition of Spartan entities On November 10, 2021, the Partnership entered into the Contribution Agreement by and among the Partnership, the general partner, Spartan, and Compressco Sub. Pursuant to the terms of the Contribution Agreement, Spartan contributed to the Partnership 100% of the limited liability company interest in Treating Holdco, 100% of the common stock in Spartan Terminals, and 99% of the limited liability company interests in Spartan Operating and the general partner agreed to cancel its IDRs in the Partnership in exchange for 48.4 million common units representing the limited partner interests in the Partnership. We refer to the acquisition of the Contributed Interests as the Spartan Acquisition. The general partner agreed to cancel its IDRs in the Partnership within 60 days of the Spartan Acquisition, and amended and restated its limited partnership agreement on January 6, 2022 to effect such cancellation. In connection with the Spartan Acquisition, we closed a private placement of common units to certain investors for gross proceeds of $52.7 million (the “Private Placement”). Spartan and General Partner Ownership As of March 31, 2022, Spartan’s ownership interest in us was approximately 45.5%, with the common units held by the public representing an approximate 55% interest in us. As of March 31, 2022, Spartan’s ownership was through various wholly owned subsidiaries and consisted of approximately 45.0% of the limited partner interests plus the approximate 0.5% general partner interest. As a result of its ownership of common units and its general partner interest in us, Spartan received distributions of $0.6 million during the three months ended March 31, 2022. Prior to the GP sale, as a result of its ownership of common units and its general partner interest in us, TETRA received distributions of $0.1 million during the three months ended March 31, 2021. Indemnification Agreement We anticipate entering into indemnification agreements with each of our current directors and officers with regard to their services as a director or officer, in order to enhance the indemnification rights provided under Delaware law and our Partnership Agreement. The individual indemnification agreements provide each such director or officer with the right to receive his or her costs of defense if he or she is made a party or witness to any proceeding other than a proceeding brought by or in the right of us, provided that such director or officer has not acted in bad faith or engaged in fraud with respect to the action that gave rise to his or her participation in the proceeding. Other Sources of Financing In February 2019, we entered into a transaction with TETRA whereby TETRA agreed to fund the construction of and purchase from us up to $15.0 million of new compression services equipment and to subsequently lease the equipment back to us in exchange for a monthly rental fee. Pursuant to this arrangement, $14.8 million was funded by TETRA for the construction of new compressor services equipment and all compression units were completed and deployed under this agreement. For accounting purposes, the inclusion of a repurchase option that allowed us to repurchase the equipment at a fixed price during certain periods of the agreement caused the transaction to be accounted for as a financing transaction, as opposed to a sale-leaseback, resulting in the funded amount being recorded as a financing obligation. Accordingly, the compressor services equipment was included in property, plant, and equipment and corresponding financing obligations were included in amounts payable to affiliates and long-term affiliate payable in our consolidated balance sheet as of December 31, 2020. In December 2020, TETRA sold these compressors and assigned the corresponding leases to Spartan Energy Partners LP (“Spartan”). In January 2021, TETRA sold the general partner, IDRs and a majority of its common units in the Partnership to Spartan who assumed the financing obligation. On November 10, 2021, the Partnership completed the Spartan Acquisition. See ‘ Acquisition of Spartan entities’ for further description above. This resulted in the reassessment of the lease as an operating lease, thus the Partnership derecognized the assets and the related liabilities as of November 10, 2021. Additionally, all revenue and expenses were eliminated in consolidation. Mexico Payroll Affiliate In January 2021, the Partnership entered into an agreement to purchase a TETRA-owned entity, which administers payroll in Mexico, for consideration of approximately $0.4 million. The difference between the fair value of the affiliate and TETRA’s historic carrying value of the affiliates’ net assets was recorded as a capital distribution. The associated liability was paid in April 2021.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	FAIR VALUE MEASUREMENTS Fair value is defined by ASC Topic 820 as “the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date” within an entity’s principal market, if any. The principal market is the market in which the reporting entity would sell the asset or transfer the liability with the greatest volume and level of activity, regardless of whether it is the market in which the entity will ultimately transact for a particular asset or liability or if a different market is potentially more advantageous. Accordingly, this exit price concept may result in a fair value that may differ from the transaction price or market price of the asset or liability. Under U.S. GAAP, the fair value hierarchy prioritizes inputs to valuation techniques used to measure fair value. Fair value measurements should maximize the use of observable inputs and minimize the use of unobservable inputs, where possible. Observable inputs are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs may be needed to measure fair value in situations where there is little or no market activity for the asset or liability at the measurement date and are developed based on the best information available in the circumstances, which could include the reporting entity’s own judgments about the assumptions market participants would utilize in pricing the asset or liability. Financial Instruments Derivative Contracts We have currency exchange rate risk exposure related to transactions denominated in a foreign currency as well as to investments in certain of our international operations. We enter into 30-day foreign currency forward derivative contracts as part of a program designed to mitigate the currency exchange rate risk exposure on selected transactions of certain foreign subsidiaries. As of March 31, 2022, we had the following foreign currency derivative contract outstanding relating to a portion of our foreign operations: Derivative contracts US Dollar Notional Amount Traded Exchange Rate Settlement Date (In Thousands) Forward sale Mexican peso $ 18,566 21.01 4/4/2022 Under a program designed to mitigate the currency exchange rate risk exposure on selected transactions of certain foreign subsidiaries, we may enter into similar derivative contracts from time to time. Although contracts pursuant to this program will serve as economic hedges of the cash flow of our currency exchange risk exposure, they will not be formally designated as hedge contracts or qualify for hedge accounting treatment. Accordingly, any change in the fair value of these derivative instruments during a period will be included in the determination of earnings for that period. The fair values of our foreign currency derivative contracts are based on quoted market values (a Level 2 fair value measurement). None of our foreign currency derivative instruments contains credit risk related contingent features that would require us to post assets or collateral for contracts that are classified as liabilities. During the three-month periods ended March 31, 2022 and March 31, 2021, we recognized $1.1 million and $(0.1) million, respectively, of net (gains) losses associated with our foreign currency derivatives program. These amounts are included in other (income) expense, net, in the accompanying consolidated statement of operations. Fair Value of Debt The fair value of our debt has been estimated in accordance with the accounting standard regarding fair value. The fair value of our fixed rate long-term debt is estimated based on recent trades for these notes. The carrying and fair value of our debt, excluding unamortized debt issuance costs, are as follows (in thousands): March 31, 2022 December 31, 2021 Carrying Value Fair Value Carrying Value Fair Value (In Thousands) 7.50% First Lien Notes $ 400,000 $ 392,000 $ 400,000 $ 405,000 10.00%/10.75% Second Lien Notes 172,717 167,751 172,717 168,399 $ 572,717 $ 559,751 $ 572,717 $ 573,399 Other

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	INCOME TAXES As a partnership, we are generally not subject to income taxes at the entity level because our income is included in the tax returns of our partners. Our operations are treated as a partnership for federal tax purposes with each partner being separately taxed on its share of taxable income. However, a portion of our business is conducted through taxable U.S. corporate subsidiaries. Accordingly, a U.S. federal and state income tax provision has been reflected in the accompanying statements of operations. State tax expense relating to the Texas franchise tax liability is included in the provision for income taxes. Certain of our operations are located outside of the U.S., and the Partnership, through its foreign subsidiaries, is responsible for income taxes in these countries. Our effective tax rate for the three-month period ended March 31, 2022, was negative 14.2% primarily attributable to taxes in certain foreign jurisdictions and Texas gross margin taxes combined with losses generated in entities for which no related tax benefit has been recorded. Included in our deferred tax assets are net operating loss carryforwards and tax credits that are available to offset future income tax liabilities in the U.S. as well as in certain foreign jurisdictions.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	COMMITMENTS AND CONTINGENCIES From time to time, we are involved in litigation relating to claims arising out of our operations in the normal course of business. While the outcome of any lawsuits or other proceedings against us cannot be predicted with certainty, management does not consider it reasonably possible that a loss resulting from such lawsuits or proceedings in excess of any amounts accrued has been incurred that is expected to have a material adverse effect on our financial condition, results of operations,

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	SUBSEQUENT EVENTS On April 19, 2022, the board of directors of our general partner declared a cash distribution attributable to the quarter ended March 31, 2022 of $0.01 per outstanding common unit. This distribution equates to a distribution of $0.04 per outstanding common unit on an annualized basis. This distribution was paid on May 13, 2022 to each of the holders of common units of record as of the close of business on April 30, 2022.

Organization, Basis of Presen_2

Organization, Basis of Presentation, and Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Presentation	Presentation Our unaudited consolidated financial statements include the accounts of our wholly owned subsidiaries. All intercompany balances and transactions have been eliminated. In the opinion of our management, our unaudited consolidated financial statements as of March 31, 2022, and for the three-month periods ended March 31, 2022 and March 31, 2021 include all normal recurring adjustments that are necessary to provide a fair statement of our results for these interim periods. Operating results for the three-month period ended March 31, 2022 are not necessarily indicative of results that may be expected for the twelve months ended December 31, 2022. The accompanying unaudited consolidated financial statements have been prepared in accordance with Rule 10-01 of Regulation S-X for interim financial statements required to be filed with the U.S. Securities and Exchange Commission (“SEC”) and do not include all information and footnotes required by U.S. generally accepted accounting principles (“U.S. GAAP”) for complete financial statements. These financial statements should be read in conjunction with the financial statements for the year ended December 31, 2021 and notes thereto included in our Annual Report on Form 10-K , which we filed with the SEC on March 14, 2022. On November 10, 2021, the Partnership entered into a Contribution Agreement (the “Contribution Agreement”) by and among the Partnership, CSI Compressco GP LLC, a Delaware limited liability company (our “general partner”), Spartan Energy Partners, LP, a Delaware limited partnership (“Spartan”) and CSI Compressco Sub Inc., a Delaware corporation (“Compressco Sub”). Pursuant to the terms of the Contribution Agreement, Spartan contributed to the Partnership 100% of the limited liability company interest in Treating Holdco, LLC, a Delaware limited liability company (“Treating Holdco”), 100% of the common stock in Spartan Terminals Operating, Inc., a Delaware corporation (“Spartan Terminals”), and 99% of the limited liability company interests in Spartan Operating Company LLC, a Delaware limited liability company (“Spartan Operating” and together with Treating Holdco and Spartan Terminals, “Spartan Treating”) (such interests in Spartan Treating, the “Contributed Interests”) in exchange for 48.4 million common units in the partnership. We refer to the acquisition of the contributed interests as the “Spartan Acquisition.” The Spartan Acquisition was accounted for as a change in reporting entity between entities under common control in accordance with ASC 250-10-45-21. A change in reporting entity requires retrospective application for all periods as if the Spartan Acquisition had been in effect since inception of common control. As a result, the consolidated financial statements and notes thereto for the Partnership reflected in this report have been prepared as if the change in reporting entity occurred on January 29, 2021. See Note 4 - “Common Control Acquisition,” for a description of the transaction.
Segments	Segments Our general partner has concluded that we operate in one reportable segment.
Business Combinations	Business CombinationsWhen we acquire a business from an entity under common control, whereby the companies are ultimately controlled by the same party or parties both before and after the transaction, it is treated similar to the pooling of interests method of accounting. The assets and liabilities are recorded at the transferring entity’s historical cost instead of reflecting the fair value of assets and liabilities. Accordingly, the financial statements reflect the combined entities at historical carrying values from the date of common control for the three months ended March 31, 2022 and March 31,2021.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclose contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues, expenses, and impairments during the reporting period. Actual results could differ from those estimates, and such differences could be material.
Reclassifications	Reclassifications C ertain previously reported financial information has been reclassified to conform to the current year’s presentation. Unless otherwise noted, amounts and disclosures throughout these Notes to Consolidated Financial Statements relate solely to continuing operations and exclude all discontinued operations.
Cash Equivalents	Cash EquivalentsWe consider all highly liquid cash investments with maturities of three months or less when purchased to be cash equivalents. We have concentrated credit risk for cash by maintaining deposits in a major bank, which may at times exceed amounts covered by insurance provided by the United States Federal Deposit Insurance Corporation (“FDIC”). We monitor the financial health of the bank and have not experienced any losses in such accounts and believe we are not exposed to any significant credit risk. Management believes the financial institutions are financially sound and risk of loss is minimal.
Financial Instruments	Financial Instruments Financial instruments that subject us to concentrations of credit risk consist principally of trade accounts receivable, which are primarily due from companies of varying size engaged in oil and gas activities in the United States, Canada, Mexico, Argentina, Chile and Egypt. Our policy is to review the financial condition of customers before extending credit and periodically updating customer credit information. Payment terms are on a short-term basis. The risk of loss from the inability to collect trade receivables is heightened during prolonged periods of low oil and natural gas commodity prices. We have currency exchange rate risk exposure related to transactions denominated in a foreign currency as well as to investments in certain of our international operations. Our risk management activities include the use of foreign currency forward purchase and sale derivative contracts as part of a program designed to mitigate the currency exchange rate risk exposure on selected international operations. We have $58.5 million outstanding under our variable rate revolving credit facilities as of March 31, 2022 and face market risk exposure related to changes in applicable interest rates.
Foreign Currencies	Foreign Currencies We have designated the Canadian dollar as the functional currency for our operations in Canada. We are exposed to fluctuations between the U.S. dollar and certain foreign currencies, including the Canadian dollar, the Mexican peso, the Argentine peso, the Egyptian pound, and the Chilean peso as a result of our international operations. Foreign currency exchange (gains) losses are included in other (income) expense, net and totaled $0.4 million and $0.4 million during the three-month periods ended March 31, 2022 and 2021 , respectively.
Leases, Lessee	Lessee As a lessee, unless the lease meets the criteria of short-term and is excluded per our policy election described below, we initially recognize a lease liability and related right-of-use asset on the commencement date. The right-of-use asset represents our right to use an underlying asset and the lease liability represents our obligation to make lease payments to the lessor over the lease term. All of our long-term leases are operating leases and are included in operating lease right-of-use assets, accrued liabilities and other, and operating lease liabilities in our consolidated balance sheet as of March 31, 2022 and December 31, 2021. We determine whether a contract is or contains a lease at inception of the contract. Where we are a lessee in a contract that includes an option to extend or terminate the lease, we include the extension period or exclude the period covered by the termination option in our lease term in determining the right-of-use asset and lease liability, if it is reasonably certain that we would exercise the option. As an accounting policy election, we do not include short-term leases on our balance sheet. Short-term leases include leases with a term of 12 months or less, inclusive of renewal options we are reasonably certain to exercise. The lease payments for short-term leases are included as operating lease costs on a straight-line basis over the lease term in cost of revenues or selling, general, and administrative expense based on the use of the underlying asset. We recognize lease costs for variable lease payments not included in the determination of a lease liability in the period in which an obligation is incurred. As allowed by U.S. GAAP, we do not separate nonlease components from the associated lease component for our contract services contracts and instead account for those components as a single component based on the accounting treatment of the predominant component. In our evaluation of whether Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 842 “Leases” or ASC 606 “Revenue from Contracts with Customers” is applicable to the combined component based on the predominant component, we determined the services nonlease component is predominant, resulting in the ongoing recognition of our compression services contracts following ASC 606. Our operating leases are recognized at the present value of lease payments over the lease term. When the implicit discount rate is not readily determinable, we use our incremental borrowing rate to calculate the discount rate used to determine the present value of lease payments. Consistent with other long-lived assets or asset groups that are held and used, we test for impairment of our right-of-use assets when impairment indicators are present.
Leases, Lessor	Lessor Our agreements for rental equipment contain an operating lease component under ASC 842 because we, as the lessor, retain substantial exposure to changes in the underlying asset’s value, unlike a sale or secured lending arrangement. Therefore, we do not unrecognize the underlying asset, and recognize income associated with providing the lessee the right to control the use of the asset ratably over the lease term. As a lessor, we recognize operating lease revenue on our statements of operations as equipment rentals. This revenue is recognized on a straight-line basis over the term of the lease based on the monthly rate in the agreement. The leased asset remains on the balance sheets consistent with other property, plant and equipment. Cash receipts associated with all leases are classified as cash flows from operating activities in the statements of cash flows.
Inventories	Inventories Inventories consist primarily of compressor package parts and supplies and work in process and are stated at the lower of cost or net realizable value. For parts and supplies, cost is determined using the weighted average cost
Impairment and Other Charges	Impairments and Other Charges Impairments of long-lived assets, including identified intangible assets, are determined periodically, when indicators of impairment are present. If such indicators are present, the determination of the amount of impairment is based on our judgments as to the future undiscounted operating cash flows to be generated from the relevant assets throughout their remaining estimated useful lives. If these undiscounted cash flows are less than the carrying amount of the related asset, an impairment is recognized for the excess of the carrying value over its fair value. Fair value of intangible assets is generally determined using the discounted present value of future cash flows using discount rates commensurate with the risks inherent with the specific assets. Assets held for disposal are recorded at the lower of carrying value or estimated fair value less estimated selling costs. We did not record any impairments of long-lived assets during the three-month periods ended March 31, 2022 and March 31, 2021.
Income Taxes	Income Taxes Our operations are not subject to U.S. federal income tax other than the operations that are conducted through taxable subsidiaries. We incur state and local income taxes in certain areas of the U.S. in which we conduct business. We incur income taxes and are subject to withholding requirements related to certain of our operations in Latin America, Canada, and other foreign countries in which we operate. Furthermore, we also incur Texas Margin Tax, which, in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 740, is classified as an income tax for reporting purposes. A portion of the carrying value of certain deferred tax assets is subject to a valuation allowance.
Earnings Per Common Unit	Earnings Per Common Unit Our computations of earnings per common unit are based on the weighted average number of common units outstanding during the applicable period. Basic earnings per common unit are determined by dividing net income (loss) allocated to the common units after deducting the amount allocated to our g eneral partner (including any distributions to our g eneral partner on its incentive distribution rights) by the weighted average number of outstanding common units during the period. When computing earnings per common unit under the two class method in periods when distributions are greater than earnings, the amount of the distribution is deducted from net income (loss) and the excess of distributions over earnings is allocated between the general partner and common units based on how our Partnership Agreement allocates net losses. Diluted earnings per common unit are computed using the treasury stock method, which considers the potential future issuance of limited partner common units. Unvested phantom units are not included in basic earnings per common unit, as they are not considered to be participating securities, but are included in the calculation of diluted earnings per common unit. For the three-month periods ended March 31, 2022 and March 31, 2021, all unvested phantom units were excluded from the calculation of diluted common units because the impact was anti-dilutive.
Fair Value Measurements	Fair Value Measurements We utilize fair value measurements to account for certain items and account balances within our consolidated financial statements. We utilize fair value measurements on a recurring basis in the accounting for our foreign currency forward purchase and sale derivative contracts. For these fair value measurements, we utilize the quoted value (a Level 2 fair value measurement). Refer to Note 9 – “Fair Value Measurements” for further discussion.
Distributions	DistributionsOn April 19, 2022, the board of directors of our general partner declared a cash distribution attributable to the quarter ended March 31, 2022 of $0.01 per outstanding common unit. This distribution equates to a distribution of $0.04 per outstanding common unit on an annualized basis. This quarterly distribution was paid on May 13, 2022 to each of the holders of common units of record as of the close of business on April 30, 2022.
New Accounting Pronouncements	New Accounting Pronouncements Standards adopted in 2022 We did not adopt any new standards in 2022. Standards not yet adopted In June 2016, the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” ASU 2016-13 amends the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which will result in the more timely recognition of losses on financial instruments not accounted for at fair value through net income. The provisions require credit impairments to be measured over the contractual life of an asset and developed with consideration for past events, current conditions, and forecasts of future economic information. Credit impairments will be accounted for as an allowance for credit losses deducted from the amortized cost basis at each reporting date. Updates at each reporting date after initial adoption will be recorded through selling, general, and administrative expense. ASU 2016-13 is effective for us the first quarter of the 2023 fiscal year. We continue to assess the potential effects of these changes to our consolidated financial statements.

Discontinued Operations (Tables

Discontinued Operations (Tables)	3 Months Ended
	Mar. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]
Disposal Groups, Including Discontinued Operations	A summary of financial information related to our discontinued operations for the new unit sales business is as follows: Reconciliation of the Line Items Constituting Pretax Loss from Discontinued Operations to the After-Tax Income (Loss) from Discontinued Operations (in thousands) Three Months Ended 2022 2021 Revenue $ — $ — Cost of revenues — 22 Depreciation and amortization — — Impairments of long-lived assets — — General and administrative expense — 40 Total pretax loss from discontinued operations — (62) Income tax provision — — Total loss from discontinued operations $ — $ (62) Reconciliation of Major Classes of Assets and Liabilities of the Discontinued Operations to Amounts Presented Separately in the Statement of Financial Position (in thousands) March 31, 2022 December 31, 2021 Carrying amounts of major classes of assets included as part of discontinued operations Inventories $ — $ — Other Current Assets — — Current assets of discontinued operations $ — $ — Carrying amounts of major classes of liabilities included as part of discontinued operations Accrued liabilities $ 262 $ 262 Current liabilities of discontinued operations $ 262 $ 262

Revenue from Contracts with C_2

Revenue from Contracts with Customers (Tables)	3 Months Ended
	Mar. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction	Expected revenue to be recognized in the future as of March 31, 2022 for completion of performance obligations of compression service contracts are as follows: 2022 2023 2024 2025 Thereafter Total (In Thousands) Compression service contracts remaining performance obligations $ 42,970 $ 16,623 $ 3,343 $ 216 $ 120 $ 63,272
Summary of Changes in Unearned Income in Balance Sheets	The following table reflects the changes in unearned income in our consolidated balance sheets for the periods indicated: Three Months Ended 2022 2021 (In Thousands) Unearned income, beginning of period $ 2,187 $ 670 Additional unearned income 2,339 314 Revenue recognized (1,773) (320) Unearned income, end of period $ 2,753 $ 664
Disaggregation of Revenue	Disaggregated revenue from contracts with customers by geography is as follows: Three Months Ended 2022 2021 (In Thousands) Contract services United States $ 52,926 $ 47,878 International 9,881 8,359 62,807 56,237 Aftermarket services United States 12,689 10,843 International 179 191 12,868 11,034 Equipment rentals United States 1,966 1,140 International 1,534 885 3,500 2,025 Equipment sales United States 715 470 International 122 — 837 470 Total Revenue United States 68,296 60,331 International 11,716 9,435 $ 80,012 $ 69,766

Common Control Acquisition (Tab

Common Control Acquisition (Tables)	3 Months Ended
	Mar. 31, 2022
Business Combinations [Abstract]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	Assets acquired and liabilities assumed are reported at their historical carrying amounts. The balance sheet of Spartan Treating on November 10, 2021, the date of acquisition, consisted of (in thousands): Current assets $ 6,616 Property, plant, and equipment 112,972 Less accumulated depreciation (53,039) Net property, plant, and equipment 59,933 Other assets 1,245 Total assets 67,794 Current liabilities 7,597 Long-term debt, net 32,590 Other liabilities 239 Total liabilities 40,426 Net assets $ 27,368
Schedule of Business Acquisitions, by Acquisition	The following tables include unaudited pro-forma financial information and the effect of the Spartan Acquisition after elimination of intercompany transactions. Three Months Ended March 31, 2021 CSI Spartan Treating Total (In Thousands, Unaudited) Revenue $ 65,710 $ 4,056 $ 69,766 Income (loss) from continuing operations $ (12,896) $ 1,769 $ (11,127) Net income (loss) $ (14,464) $ 1,569 $ (12,895)

Inventories (Tables)

Inventories (Tables)	3 Months Ended
	Mar. 31, 2022
Inventory Disclosure [Abstract]
Components of Inventories	Components of inventories as of March 31, 2022 and December 31, 2021, are as follows: March 31, 2022 December 31, 2021 (In Thousands) Parts and supplies $ 35,494 $ 31,441 Work in progress 2,866 1,830 Total inventories $ 38,360 $ 33,271

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2022
Leases [Abstract]
Operating Lease, Lease Income	We recognized operating lease revenue, which is included in “Equipment rentals” on the consolidated statements of operations as follows: March 31, 2022 March 31, 2021 (In Thousands) Equipment rentals 3,500 $ 2,025
Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity	The following table presents the undiscounted cash flows expected to be received related to these agreements: 2022 2023 2024 2025 2026 Thereafter (In Thousands) Future minimum lease revenue $ 8,807 5,518 1,744 1,599 1,576 3,421

Long-Term Debt and Other Borr_2

Long-Term Debt and Other Borrowings (Tables)	3 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Summary of Long-term Debt	Long-term debt consists of the following: Scheduled Maturity March 31, 2022 December 31, 2021 (In Thousands) Credit Agreement (1) June 29, 2023 $ — $ 330 Spartan Credit Agreement (2) January 29, 2024 57,621 58,045 7.50% First Lien Notes due 2025 (3) April 1, 2025 398,964 399,767 10.00%/10.75% Second Lien Notes due 2026 (4) April 1, 2026 173,597 172,999 Total long-term debt $ 630,182 $ 631,141 (1) Net of unamortized deferred financing costs of $0.5 million as of December 31, 2021. Because there was no outstanding balance on the Credit Agreement, associated deferred financing costs of $0.1 million as of March 31, 2022 were classified as other long-term assets on the accompanying consolidated balance sheet. (2) Net of unamortized deferred financing costs of $0.9 million and $1.0 million as of March 31, 2022 and December 31, 2021, respectively. (3) Net of unamortized deferred financing costs of $4.2 million and $3.9 million as of March 31, 2022 and December 31, 2021, respectively, unamortized discount of $0.5 million and $0.2 million as of March 31, 2022 and December 31, 2021, respectively, and deferred restructuring gain of $3.6 million and $3.9 million as of March 31, 2022 and December 31, 2021, respectively. (4) Net of unamortized deferred financing costs of $1.2 million and $2.0 million as of March 31, 2022 and December 31, 2021, respectively, unamortized discount of $0.8 million and $0.9 million as of March 31, 2022 and December 31, 2021, respectively, and deferred restructuring gain of $2.9 million and $3.1 million as of March 31, 2022 and December 31, 2021, respectively.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of Notional Amounts of Outstanding Derivative Positions Table	As of March 31, 2022, we had the following foreign currency derivative contract outstanding relating to a portion of our foreign operations: Derivative contracts US Dollar Notional Amount Traded Exchange Rate Settlement Date (In Thousands) Forward sale Mexican peso $ 18,566 21.01 4/4/2022
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments	The carrying and fair value of our debt, excluding unamortized debt issuance costs, are as follows (in thousands): March 31, 2022 December 31, 2021 Carrying Value Fair Value Carrying Value Fair Value (In Thousands) 7.50% First Lien Notes $ 400,000 $ 392,000 $ 400,000 $ 405,000 10.00%/10.75% Second Lien Notes 172,717 167,751 172,717 168,399 $ 572,717 $ 559,751 $ 572,717 $ 573,399

Organization, Basis of Presen_3

Organization, Basis of Presentation, and Significant Accounting Policies (Details) $ / shares in Units, shares in Millions, $ in Millions	Apr. 19, 2022$ / shares	Nov. 10, 2021shares	Mar. 31, 2022USD ($)segment	Mar. 31, 2021USD ($)
Debt Instrument [Line Items]
Number of operating segments | segment			1
Number of reportable segments | segment			1
Foreign currency exchange (gains) losses | $			$ 0.4	$ 0.4
Subsequent Event
Debt Instrument [Line Items]
Distribution declared, quarterly basis (in USD per common unit) | $ / shares	$ 0.01
Distribution declared, annualized basis (in USD per common unit) | $ / shares	$ 0.04
Spartan Treating
Debt Instrument [Line Items]
Business combination, consideration transferred, equity interests issued and issuable (in units) | shares		48.4
Spartan Energy Partners LP | Treating Holdco LLC
Debt Instrument [Line Items]
Percentage of ownership before transaction		100.00%
Spartan Energy Partners LP | Spartan Terminals Operating, Inc.
Debt Instrument [Line Items]
Percentage of ownership before transaction		100.00%
Spartan Energy Partners LP | Spartan Operating Company, LLC
Debt Instrument [Line Items]
Percentage of ownership before transaction		99.00%

Discontinued Operations (Detail

Discontinued Operations (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]
Revenue	$ 0	$ 0
Cost of revenues	0	22
Depreciation and amortization	0	0
Impairments of long-lived assets	0	0
General and administrative expense	0	40
Total pretax loss from discontinued operations	0	(62)
Income tax provision	0	0
Total loss from discontinued operations	0	$ (62)
Carrying amounts of major classes of assets included as part of discontinued operations
Inventories	0		$ 0
Other Current Assets	0		0
Current assets of discontinued operations	0		0
Carrying amounts of major classes of liabilities included as part of discontinued operations
Accrued liabilities	262		262
Current liabilities of discontinued operations	$ 262		$ 262

Revenue from Contracts with C_3

Revenue from Contracts with Customers - Narrative (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Revenue, remaining performance obligation	$ 63,272
Contract with customer, asset, before allowance for credit loss	$ 5,600	$ 4,100

Revenue from Contracts with C_4

Revenue from Contracts with Customers - Revenue Performance Obligations (Details) $ in Thousands	Mar. 31, 2022USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation	$ 63,272
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction	9 months
Revenue, remaining performance obligation	$ 42,970
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction	1 year
Revenue, remaining performance obligation	$ 16,623
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction	1 year
Revenue, remaining performance obligation	$ 3,343
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction	1 year
Revenue, remaining performance obligation	$ 216
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction
Revenue, remaining performance obligation	$ 120

Revenue from Contracts with C_5

Revenue from Contracts with Customers - Contract Assets and Liabilities (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Contract With Customer, Change In Contract Liability [Roll Forward]
Unearned income, beginning of period	$ 2,187	$ 670
Additional unearned income	2,339	314
Revenue recognized	(1,773)	(320)
Unearned income, end of period	$ 2,753	$ 664

Revenue from Contracts with C_6

Revenue from Contracts with Customers - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Disaggregation of Revenue [Line Items]
Total revenues	$ 80,012	$ 69,766
United States
Disaggregation of Revenue [Line Items]
Total revenues	68,296	60,331
International
Disaggregation of Revenue [Line Items]
Total revenues	11,716	9,435
Contract services
Disaggregation of Revenue [Line Items]
Total revenues	62,807	56,237
Contract services | United States
Disaggregation of Revenue [Line Items]
Total revenues	52,926	47,878
Contract services | International
Disaggregation of Revenue [Line Items]
Total revenues	9,881	8,359
Aftermarket services
Disaggregation of Revenue [Line Items]
Total revenues	12,868	11,034
Aftermarket services | United States
Disaggregation of Revenue [Line Items]
Total revenues	12,689	10,843
Aftermarket services | International
Disaggregation of Revenue [Line Items]
Total revenues	179	191
Equipment rentals
Disaggregation of Revenue [Line Items]
Total revenues	3,500	2,025
Equipment rentals | United States
Disaggregation of Revenue [Line Items]
Total revenues	1,966	1,140
Equipment rentals | International
Disaggregation of Revenue [Line Items]
Total revenues	1,534	885
Equipment sales
Disaggregation of Revenue [Line Items]
Total revenues	837	470
Equipment sales | United States
Disaggregation of Revenue [Line Items]
Total revenues	715	470
Equipment sales | International
Disaggregation of Revenue [Line Items]
Total revenues	$ 122	$ 0

Common Control Acquisition - Ad

Common Control Acquisition - Additional Information (Details) - USD ($) $ in Thousands, shares in Millions	Nov. 10, 2021	Mar. 31, 2022	Mar. 31, 2021
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Distributions		$ 1,411	$ 484
Net income (loss)		$ (6,570)	$ (12,895)
Spartan Treating
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Partners' capital	$ 27,400
Net income (loss)	$ 1,600
Spartan Treating
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Business combination, consideration transferred, equity interests issued and issuable (in units)	48.4
Business combination, consideration transferred, equity interests issued or issuable, value	$ 65,300
Distributions	$ 37,900

Common Control Acquisition - Sc

Common Control Acquisition - Schedule of Assets Acquired and Liabilities Assumed (Details) $ in Thousands	Nov. 10, 2021USD ($)
Business Combinations [Abstract]
Current assets	$ 6,616
Property, plant, and equipment	112,972
Less accumulated depreciation	(53,039)
Net property, plant, and equipment	59,933
Other assets	1,245
Total assets	67,794
Current liabilities	7,597
Long-term debt, net	32,590
Other liabilities	239
Total liabilities	40,426
Net assets	$ 27,368

Common Control Acquisition - Pr

Common Control Acquisition - Pro-Forma Financial Information (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2020USD ($)
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Revenue	$ 69,766
Income (loss) from continuing operations	(11,127)
Net income (loss)	(12,895)
Subsidiaries | CSI Compressco LP
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Revenue	65,710
Income (loss) from continuing operations	(12,896)
Net income (loss)	(14,464)
Subsidiaries | Spartan Treating
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Revenue	4,056
Income (loss) from continuing operations	1,769
Net income (loss)	$ 1,569

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Inventory Disclosure [Abstract]
Parts and supplies	$ 35,494	$ 31,441
Work in progress	2,866	1,830
Total inventories	$ 38,360	$ 33,271

Leases - Lessor Operating Lease

Leases - Lessor Operating Lease Revenue (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2022USD ($)
Leases [Abstract]
Equipment rentals	$ 3,500

Leases - Lessor Narrative (Deta

Leases - Lessor Narrative (Details)	Mar. 31, 2022
Minimum
Lessee, Lease, Description [Line Items]
Lessor, operating lease, remaining lease term	1 month
Maximum
Lessee, Lease, Description [Line Items]
Lessor, operating lease, remaining lease term	7 years

Leases - Lessor Future Minimum

Leases - Lessor Future Minimum Lease Revenue (Details) $ in Thousands	Mar. 31, 2022USD ($)
Leases [Abstract]
2022	$ 8,807
2023	5,518
2024	1,744
2025	1,599
2026	1,576
Thereafter	$ 3,421

Long-Term Debt and Other Borr_3

Long-Term Debt and Other Borrowings - Summary of Long-term Debt (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Long-term debt	$ 630,182	$ 631,141
Line of Credit | Credit Agreement
Debt Instrument [Line Items]
Long-term debt	0	330
Unamortized deferred financing costs	100	500
Line of Credit | Spartan Credit Agreement
Debt Instrument [Line Items]
Long-term debt	57,621	58,045
Unamortized deferred financing costs	900	1,000
Secured Debt | 7.50% First Lien Notes
Debt Instrument [Line Items]
Long-term debt	$ 398,964	399,767
Interest rate	7.50%
Unamortized deferred financing costs	$ 4,200	3,900
Unamortized discount	500	200
Gain on restructuring of debt	3,600	3,900
Secured Debt | 10.00%/10.75% Second Lien Notes
Debt Instrument [Line Items]
Long-term debt	173,597	172,999
Unamortized deferred financing costs	1,200	2,000
Unamortized discount	800	900
Gain on restructuring of debt	$ 2,900	$ 3,100
Secured Debt | 10.00%/10.75% Second Lien Notes | Minimum
Debt Instrument [Line Items]
Interest rate	10.00%
Secured Debt | 10.00%/10.75% Second Lien Notes | Maximum
Debt Instrument [Line Items]
Interest rate	10.75%

Long-Term Debt and Other Borr_4

Long-Term Debt and Other Borrowings - Narrative (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Nov. 10, 2021	Nov. 09, 2021	Apr. 30, 2021	Jan. 29, 2021	Jun. 11, 2020
Debt Instrument [Line Items]
Long-term debt	$ 630,182,000	$ 631,141,000
7.50% First Lien Notes | Secured Debt
Debt Instrument [Line Items]
Interest rate	7.50%
Long-term debt	$ 398,964,000	399,767,000
10.00%/10.75% Second Lien Notes | Secured Debt
Debt Instrument [Line Items]
Long-term debt, gross			$ 10,000,000
Long-term debt	173,597,000	172,999,000
10.00%/10.75% Second Lien Notes | PIK Notes
Debt Instrument [Line Items]
Long-term debt	$ 7,200,000
10.00%/10.75% Second Lien Notes | Minimum | Secured Debt
Debt Instrument [Line Items]
Interest rate	10.00%
10.00%/10.75% Second Lien Notes | Maximum | Secured Debt
Debt Instrument [Line Items]
Interest rate	10.75%
Second Lien Notes Indenture | PIK Notes | Rate 1
Debt Instrument [Line Items]
Interest rate	7.25%
Second Lien Notes Indenture | PIK Notes | Rate 2
Debt Instrument [Line Items]
Interest rate	2.75%
Second Lien Notes Indenture | PIK Notes | Rate 3
Debt Instrument [Line Items]
Interest rate	3.50%
Finance Agreement
Debt Instrument [Line Items]
Long-term debt, gross	$ 7,800,000
Monthly installment	$ 200,000
Debt instrument, term	36 months
Revolving Credit Facility | Credit Agreement
Debt Instrument [Line Items]
Maximum revolving credit commitments							$ 35,000,000
Reserve amount					$ 5,000,000	$ 10,000,000	5,000,000
Credit agreement availability	$ 21,100,000
Outstanding balance	0
Revolving Credit Facility | Credit Agreement Sublimit
Debt Instrument [Line Items]
Credit agreement sublimit							$ 25,000,000
Letters of credit, balance outstanding	2,100,000
Line of Credit | Spartan Credit Agreement
Debt Instrument [Line Items]
Maximum revolving credit commitments			$ 70,000,000	$ 55,000,000
Credit agreement availability		$ 5,100,000
Outstanding balance	58,500,000
Letters of credit, balance outstanding	$ 0

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($) shares in Thousands, $ in Thousands	Nov. 10, 2021	Jan. 31, 2021	Feb. 28, 2019	Mar. 31, 2022	Mar. 31, 2021	Jan. 29, 2021
Related Party Transaction [Line Items]
Distributions				$ (1,411)	$ (484)
Spartan Treating
Related Party Transaction [Line Items]
Business combination, consideration transferred, equity interests issued and issuable (in units)	48,400
Distributions	$ (37,900)
TETRA
Related Party Transaction [Line Items]
Long-term affiliate payable			$ 15,000
Advances from affiliate			$ 14,800
TETRA | Mexico Payroll Affiliate
Related Party Transaction [Line Items]
Consideration transferred		$ 400
Spartan Entities Acquisition | Spartan Treating
Related Party Transaction [Line Items]
Business combination, consideration transferred, equity interests issued and issuable (in units)	48,400
Business combination, incentive distribution rights, cancelation period	60 days
Spartan Entities Acquisition | Spartan Treating | Private Placement
Related Party Transaction [Line Items]
Sale of common units, consideration received on transaction	$ 52,700
Spartan Entities Acquisition | Spartan Energy Partners LP | Treating Holdco LLC
Related Party Transaction [Line Items]
Percentage of ownership before transaction	100.00%
Spartan Entities Acquisition | Spartan Energy Partners LP | Spartan Terminals Operating, Inc.
Related Party Transaction [Line Items]
Percentage of ownership before transaction	100.00%
Spartan Entities Acquisition | Spartan Energy Partners LP | Spartan Operating Company, LLC
Related Party Transaction [Line Items]
Percentage of ownership before transaction	99.00%
Spartan Energy Partners LP
Related Party Transaction [Line Items]
Limited liability company interest				45.50%
Public ownership interest				45.00%
General Partner percentage interest				0.50%
Common Unitholders
Related Party Transaction [Line Items]
Public ownership interest				55.00%
Spartan Energy Partners LP
Related Party Transaction [Line Items]
Distributions				$ (600)
Spartan Energy Partners LP | CSI Compressco LP
Related Party Transaction [Line Items]
Investment owned (in units)						10,950
TETRA
Related Party Transaction [Line Items]
Distributions				$ (100)
TETRA | CSI Compressco LP
Related Party Transaction [Line Items]
Investment owned (in units)						5,200

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Foreign Currency Derivative Contract Outstanding (Details) - Forward sale Mexican peso $ in Thousands	Mar. 31, 2022USD ($)
Derivative [Line Items]
US Dollar Notional Amount	$ 18,566
Traded Exchange Rate	21.01

Fair Value Measurements - Narra

Fair Value Measurements - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Fair Value Disclosures [Abstract]
Net gain (loss) associated with foreign currency derivative program	$ 1.1	$ (0.1)

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Carrying Values and Estimated Fair Values of Debt Instruments (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Carrying Value	$ 572,717	$ 572,717
Fair Value	559,751	573,399
7.50% First Lien Notes | Secured Debt
Debt Instrument [Line Items]
Carrying Value	400,000	400,000
Fair Value	$ 392,000	405,000
Interest rate	7.50%
10.00%/10.75% Second Lien Notes | Secured Debt
Debt Instrument [Line Items]
Carrying Value	$ 172,717	172,717
Fair Value	$ 167,751	$ 168,399
10.00%/10.75% Second Lien Notes | Secured Debt | Minimum
Debt Instrument [Line Items]
Interest rate	10.00%
10.00%/10.75% Second Lien Notes | Secured Debt | Maximum
Debt Instrument [Line Items]
Interest rate	10.75%

Income Taxes (Details)

Income Taxes (Details)	3 Months Ended
	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Effective tax rate reconciliation, percent	(14.20%)

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event	Apr. 19, 2022$ / shares
Subsequent Event [Line Items]
Distribution declared, quarterly basis (in USD per common unit)	$ 0.01
Distribution declared, annualized basis (in USD per common unit)	$ 0.04